Article Details
Retrieved on: 2021-04-06 16:39:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AzurRx BioPharma has started its Phase II clinical trial to evaluate micronised oral niclosamide tablets, known as FW-1022, in patients with Covid-19 ...
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here